These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30169466)

  • 1. An update of idiopathic intracranial hypertension.
    Madriz Peralta G; Cestari DM
    Curr Opin Ophthalmol; 2018 Nov; 29(6):495-502. PubMed ID: 30169466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.
    Smith SV; Friedman DI
    Headache; 2017 Sep; 57(8):1303-1310. PubMed ID: 28758206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the Diagnosis and Treatment of Idiopathic Intracranial Hypertension.
    Bidot S; Bruce BB
    Semin Neurol; 2015 Oct; 35(5):527-38. PubMed ID: 26444398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension.
    Fraser C; Plant GT
    Curr Opin Neurol; 2011 Feb; 24(1):12-7. PubMed ID: 21150597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic intracranial hypertension (pseudotumor cerebri).
    Randhawa S; Van Stavern GP
    Curr Opin Ophthalmol; 2008 Nov; 19(6):445-53. PubMed ID: 18854688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.
    ; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ
    JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
    ten Hove MW; Friedman DI; Patel AD; Irrcher I; Wall M; McDermott MP;
    J Neuroophthalmol; 2016 Mar; 36(1):13-9. PubMed ID: 26587993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing idiopathic intracranial hypertension in the eye clinic.
    Bonelli L; Menon V; Arnold AC; Mollan SP
    Eye (Lond); 2024 Aug; 38(12):2472-2481. PubMed ID: 38789788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Idiopathic Intracranial Hypertension.
    Kanagalingam S; Subramanian PS
    Curr Treat Options Neurol; 2018 May; 20(7):24. PubMed ID: 29808423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.
    Cello KE; Keltner JL; Johnson CA; Wall M;
    J Neuroophthalmol; 2016 Mar; 36(1):6-12. PubMed ID: 26618282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on Idiopathic Intracranial Hypertension.
    Wall M
    Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic intracranial hypertension: pseudotumor cerebri.
    Kosmorsky GS
    Headache; 2014 Feb; 54(2):389-93. PubMed ID: 24512582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Intracranial Hypertension: a Current Literature Review.
    Aylward SC; Way AL
    Curr Pain Headache Rep; 2018 Feb; 22(2):14. PubMed ID: 29441432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Up to Date Review of Pseudotumor Cerebri Syndrome.
    Burkett JG; Ailani J
    Curr Neurol Neurosci Rep; 2018 May; 18(6):33. PubMed ID: 29721718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep apnea and intracranial hypertension in men.
    Lee AG; Golnik K; Kardon R; Wall M; Eggenberger E; Yedavally S
    Ophthalmology; 2002 Mar; 109(3):482-5. PubMed ID: 11874748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should topiramate be initial therapy in the management of idiopathic intracranial hypertension?: A literature review.
    Goyal A; Zarroli K
    Medicine (Baltimore); 2023 Oct; 102(42):e35545. PubMed ID: 37861536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic intracranial hypertension: pseudotumor cerebri.
    Krajewski KJ; Gurwood AS
    Optometry; 2002 Sep; 73(9):546-52. PubMed ID: 12387561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current concepts in pseudotumor cerebri.
    Hainline C; Rucker JC; Balcer LJ
    Curr Opin Neurol; 2016 Feb; 29(1):84-93. PubMed ID: 26641809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life at 6 months in the Idiopathic Intracranial Hypertension Treatment Trial.
    Bruce BB; Digre KB; McDermott MP; Schron EB; Wall M;
    Neurology; 2016 Nov; 87(18):1871-1877. PubMed ID: 27694262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal vessel diameter changes after 6 months of treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
    Moss HE; Hollar RA; Fischer WS; Feldon SE
    Br J Ophthalmol; 2020 Oct; 104(10):1430-1434. PubMed ID: 31949093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.